• Skip to main content
  • Skip to secondary menu
  • Skip to footer

ESN.net

event sharing network

  • Share Your Event
    • Make a Contribution
  • Events
  • Job Board
  • Markets
  • About
    • GDPR
    • Event Marketing: A Catalyst for Business Success
    • Leveraging Social Media for Event Promotion: A Winning Strategy
    • Targeting the Right Audience: The Key to Successful Event Promotion
    • The Power of Media: Maximizing Event Promotion through the Media
    • Capturing the Moment: The Importance of Photo and Video Coverage in Event Promotion
    • Voices of the Event: The Power of Interviews as a Promotion Tool
    • The Power of Podcasts: Using Audio as a Tool for Event Promotion
    • Bridging the Gap: How Virtual Events Complement Physical Ones and Expand Reach and Audience
    • The Future is Now: How Innovation is Revolutionizing Event Management and Promotion
  • Contact

Orexo Hosts Capital Markets Day Today in Stockholm, Sweden

December 6, 2018 By admin Leave a Comment

Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, is today hosting the Company’s Capital Markets Day for investors, analysts and media in Stockholm, Sweden.

Orexo’s management team will expand on new strategic initiatives building upon the Company’s strong financial and operational foundation, primarily driven by the performance for Zubsolv® in the US. The event will highlight the Company’s plans to further strengthen its pipeline and innovative formulation technologies. In addition, management will also elaborate on efforts to broaden the commercial platform to leverage scale and expand sales through business development and potentially M&A transactions.

With a highly positive outcome in the recent patent litigation concerning Zubsolv, Orexo’s core asset has received strengthened IP in the US until 2032. The decision has enabled Orexo to continue with its strategy to maximise Zubsolv´s potential in a fast growing US market. The team will also expand on the latest market trends and demonstrate how it intends to further strengthen its market position.

The event will be moderated by Charlotte Stjerngren, former news anchor for Börslunch, where members of the Orexo management team including among others Nikolaj Sørensen, CEO and President, Robert DeLuca, President US Inc., Johannes Doll, EVP and Head of Corporate Development, and Martin Nicklasson, Chairman of the Board of Directors will be presenting. The Keynote speaker is former New Jersey governor, Chris Christie, who will be discussing the current landscape of the opioid crisis, and how to combat it.

All presenters during the Orexo Capital Markets Day

Martin Nicklasson, Chairman of the Board of Directors, Orexo
Nikolaj Sørensen, CEO and President, Orexo
Dan Hawkins, Founder & Managing Director, Clarion Healthcare
Robert A. DeLuca, President, Orexo US Inc.
Joseph DeFeo, EVP and Chief Financial Officer, Orexo
Fred Nyberg, PhD, Professor, Division of Biological Research on Drug Dependence, Uppsala University
Johannes Doll, EVP and Head of Corporate Development, Orexo
Michael Sumner, Chief Medical Officer, Orexo
Robert Rönn, Head of Pharmaceutical Development and IP, Orexo
Chris Christie, Former Governor of New Jersey and former Chairman of the US President’s Commission on Combating Drug Addiction and the Opioid Crisis
Event details

The meeting will be held at the Armémuseet, Riddargatan 13, Stockholm, Sweden. The event will start at 12:00 noon CET with a networking lunch, followed by presentations commencing at
1:00 pm CET.

A live webcast will be available on the Orexo website and questions related to the presentations can also be sent to [email protected]. A replay of the event and presentation slides, excluding Chris Christie´s performance, will be made available shortly after.

About Orexo

Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but the aim is to address therapeutic areas where our competence and technologies can create value. The products are commercialized by Orexo in the US or via selected partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo sells the product Zubsolv®. Total net sales for 2017 amounted to SEK 643.7 million and the number of employees at year-end was 90. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the U.S. The head office, where research and development is also performed, is situated in Uppsala, Sweden.

For more information about Orexo please visit, www.orexo.com.

Filed Under: events Tagged With: pharmaceutical

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • GDC 2025 Closes with Record Attendance, Promising an Even Grander Return to Moscone Center in 2026
  • monday.com Concludes Annual Partner Summit in London Celebrating Growth and Innovation
  • AffiniPay Announces Inaugural Kaleidoscope Conference for Legal and Accounting Professionals
  • IAMPHENOM 2025 Expands Speaker Lineup with 35 Additional Industry Leaders
  • Totem’s $1.3M Funding Surge Ignites a Global Festival Connectivity Revolution
  • The New York Scientific Data Summit (NYSDS) 2024, taking place on September 16-17, 2024
  • MIT Sloan CFO Summit Presents “The Intentional CFO: Innovative and Pragmatic”
  • The Oppenheimer 27th Annual Technology, Internet & Communications Conference, August 14, 2024
  • Forrester Announces Full Conference Agenda For B2B Summit EMEA 2024
  • Timey Event: Celebrating the Preservation of Digital Heritage

Media Partners

  • Calendarial
  • Technology Conferences
  • Event Calendar
International Women in Engineering Day (INWED) is celebrated annually on June 23rd
Starpower EXPO 2025, March 7-9, 2025, North Dallas and Southlake
IMCAS 2025 in Paris: A Global Showcase of Excellence in Aesthetics
Today is World Refugee Day
SSFF & ASIA 2024 Opening Ceremony: Celebrating Asian Cinema with World Premieres and Prestigious Awards, June 4, at LINE CUBE SHIBUYA, Shibuya Ward, Japan
ZETA LIVE 2023 – The AI-Powered Marketing Cloud’s Third Annual Conference, September 28, 2023, NYC
Apple Announces WWDC25, June 9 to 13, 2025
North America’s largest and most influential additive manufacturing event, RAPID + TCT 2023, is set to take place in Chicago’s McCormick Place on May 2-4, 2023
World IT Show (WIS) Kicks Off in Seoul, Korea
Network X 2024, 8-10 October, 2024, Paris Expo Porte de Versailles, Paris
Chicago Auto Show 2024, February 10-19, 2024, McCormick Place, Chicago
LogiMAT 2025: Pioneering Intralogistics Innovations in Stuttgart
Electrify Expo Austin Set to Be Largest EV Demo Event of the 2022 Season, November 12-13, 2022, Austin, Texas
World Hydrogen Summit & Exhibition: Advancing the Hydrogen Economy, May 21-23, 2025, Rotterdam, Netherlands
NAB Show New York 2023, October 24-26, 2023 (Exhibits: October 25-26), Javits Center, New York City

Media Partners

  • Technologies.org
  • 3V.org: PR/Media Agency
  • Market Analysis
Apple Unveils the All-New MacBook Air with M4 Chip
Transforming Work and Development: AWS Unveils Groundbreaking Enhancements to Amazon Q Business and Developer
Ulu Ventures Sets a New Standard in Venture Capital with Fund IV
fal: The Generative Media Backbone Scured $49 Million
No Love Lost: The U.S.-China Trade Battle Escalates with Critical Export Bans
Andy Murray: A Legacy of Tenacity and Triumph in Tennis
Case Study in Travel Marketing: Revitalizing a Family-Run Hotel in Bergerac, France
bluShift Successfully Completed a Full Flight-Duration Engine Test Last Night at Brunswick Landing
TravelMktg.com Releases Comprehensive Guide for Travel Safety at Paris 2024 Summer Olympics
The Evolution of Press Release Distribution: Embracing Non-Traditional Channels
The Impact of Artificial Intelligence on the Accounting Profession
Key Fire Industry Trends for 2023
Datadog’s strong financial results for the fourth quarter and fiscal year 2022 provide a solid case for a Buy recommendation
Surging electric vehicle sales are already dampaning the sales of ICE vehicles and demand for gasoline and diesel fuel
One of the biggest challenges facing the $30 billion fragrance industry is the increasing difficulty of sourcing certain raw materials

Copyright © 2022 ESN.net

Media Partners: Technologies, Market Analysis & Market Research and Exclusive Domains